Activated mineralocorticoid receptor regulates micro-RNA-29b in vascular smooth muscle cells

FASEB Journal

Volumn 30, Issue 4, 2016, Pages 1610-1622

  Bretschneider, Maria ^a   Busch, Bianca ^a   Mueller, Daniel ^a   Nolze, Alexander ^a   Schreier, Barbara ^a   Gekle, Michael ^a   Grossmann, Claudia ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Aldosterone; Post transcriptional regulation; Vascular aging; Vascular disease

Indexed keywords

ALDOSTERONE; CASPASE; LACTATE DEHYDROGENASE; MICRORNA 29; MICRORNA 29B; MINERALOCORTICOID RECEPTOR; RNA; COLLAGEN; FIBRONECTIN; MICRORNA; MIRN29 MICRORNA, HUMAN; MIRN29 MICRORNA, MOUSE; TRANSCRIPTOME;

AORTA; APOPTOSIS; ARTICLE; ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL TRACKING; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PATHOGENESIS; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE CELL; AGONISTS; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CELL MOTION; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ALDOSTERONE; ANIMALS; AORTA; APOPTOSIS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; FIBRONECTINS; HUMANS; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84963815187     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-271254     Document Type: Article

References (65)

1. World Health Organization (2012) The European health report 2012: charting the way to well-being. Retrieved December 28, 2015, from http://www.euro.who.int/en/data-and-evidence/europeanhealth-report/european-health-report-2012
2. Whitley, G. S. J., and Cartwright, J. E. (2010) Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta 31, 465-474
3. Frostegard, J. (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med. 11, 117
4. Lacolley,P., Regnault,V.,Nicoletti, A.,Li, Z.,andMichel, J.-B. (2012) The vascular smoothmuscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 95, 194-204
5. Bennett,M., Yu,H., andClarke,M. (2012) Signalling fromdead cells drives inflammation and vessel remodelling. Vascul. Pharmacol. 56, 187-192
6. Gekle, M., Mildenberger, S., Freudinger, R., and Grossmann, C. (2007) Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone. Pflugers Arch. 454, 403-413
7. Davis-Dusenbery, B.N.,Wu, C., andHata, A. (2011)Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler. Thromb. Vasc. Biol. 31, 2370-2377
8. Pitt, B., Zannad, F., Remme,W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., andWittes, J.; Randomized Aldactone Evaluation Study Investigators. (1999) The effect of spironolactone onmorbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709-717
9. Pitt, B. (2004) Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol. Cell. Endocrinol. 217, 53-58
10. Young, M., Fullerton, M., Dilley, R., and Funder, J. (1994) Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 93, 2578-2583
11. Stowasser, M. (2001) New perspectives on the role of aldosterone excess in cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 28, 783-791
12. Rocha,R.,Martin-Berger,C.L., Yang, P., Scherrer,R.,Delyani, J., and McMahon, E. (2002) Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143, 4828-4836
13. Gekle, M., and Grossmann, C (2009) Actions of Aldosterone in the Cardiovascular System: The Good, the Bad, and the Ugly? Pflugers Arch. 458, 231-246
14. Callera, G. E., Touyz, R.M., Tostes, R. C., Yogi, A.,He, Y.,Malkinson, S., and Schiffrin, E. L. (2005)Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45, 773-779
15. Jaffe, I. Z., and Mendelsohn, M. E. (2005) Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smoothmuscle cells. Circ. Res. 96, 643-650
16. Iwashima, F., Yoshimoto, T., Minami, I., Sakurada, M., Hirono, Y., and Hirata, Y. (2008) Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 149, 1009-1014
17. Caprio,M.,Newfell,B.G., la Sala,A.,Baur,W., Fabbri,A.,Rosano, G., Mendelsohn, M. E., and Jaffe, I. Z. (2008) Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ. Res. 102, 1359-1367
18. Maron, B. A., Zhang, Y. Y., Handy, D. E., Beuve, A., Tang, S. S., Loscalzo, J., and Leopold, J. A. (2009) Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J. Biol. Chem. 284, 7665-7672
19. Newfell, B. G., Iyer, L. K.,Mohammad, N. N.,McGraw, A. P., Ehsan, A., Rosano, G., Huang, P. L., Mendelsohn, M. E., and Jaffe, I. Z. (2011) Aldosterone regulates vascular gene transcription via oxidative stress-dependent and-independent pathways. Arterioscler. Thromb. Vasc. Biol. 31, 1871-1880
20. Di Stefano, V., Zaccagnini, G., Capogrossi, M. C., and Martelli, F. (2011)microRNAs asperipheral bloodbiomarkers of cardiovascular disease. Vascul. Pharmacol. 55, 111-118
21. Jamaluddin, M. S.,Weakley, S.M., Zhang, L., Kougias, P., Lin, P. H., Yao, Q., and Chen, C. (2011)miRNAs: roles and clinical applications in vascular disease. Expert Rev. Mol. Diagn. 11, 79-89
22. Hartmann, D., and Thum, T. (2011)MicroRNAs and vascular (dys) function. Vascul. Pharmacol. 55, 92-105
23. Ambros, V. (2004) The functions of animal microRNAs. Nature 431, 350-355
24. He, L., andHannon, G. J. (2004)MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531
25. Macfarlane, L.-A., and Murphy, P. R. (2010) MicroRNA: biogenesis, function and role in cancer. Curr. Genomics 11, 537-561
26. Sõber, S., Laan, M., and Annilo, T. (2010) MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem. Biophys. Res. Commun. 391, 727-732
27. Nossent,A. Y.,Hansen, J.L.,Doggen, C.,Quax,P.H. A.,Sheikh, S.P., and Rosendaal, F. R. (2011) SNPs in microRNA binding sites in 39-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am. J. Hypertens. 24, 999-1006
28. Schreier, B., Rabe, S., Schneider, B., Ruhs, S., Grossmann, C., Hauptmann, S., Blessing, M., Neumann, J., and Gekle, M. (2011) Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-b responsiveness of T cells. Hypertens. Res. 34, 623-629
29. Schwerdt, G., Holzinger, H., Sauvant, C., Königs, M., Humpf, H.-U., and Gekle, M. (2007) Long-term effects of ochratoxin A on fibrosis and cell death in human proximal tubule or fibroblast cells in primary culture. Toxicology 232, 57-67
30. Schwerdt, G., Gordjani, N., Benesic, A., Freudinger, R., Wollny, B., Kirchhoff, A., and Gekle, M. (2006) Chloroacetaldehyde-and acrolein-induced death of human proximal tubule cells. Pediatr. Nephrol. 21, 60-67
31. Lane, R. D., Federman, D., Flora, J. L., and Beck, B. L. (1986) Computer-assisted determination of protein concentrations from dye-binding and bicinchoninic acid protein assays performed in microtiter plates. J. Immunol. Methods 92, 261-270
32. Bergmeyer, H. U., and Bernt, E. (1974) Laktat-Dehydrogenase. In Methoden der enzymatischen Analyse (Bergmeyer, H.U., ed.), pp. 607-612, Verlag Chemie, Weinheim, Germany
33. Hwang,H.-W.,Wentzel,E.A.,andMendell, J.T.(2007)Ahexanucleotide element directs microRNA nuclear import. Science 315, 97-100
34. Von Lueder, T. G., and Krum, H. (2013) RAAS inhibitors and cardiovascular protection in large scale trials. Cardiovasc. Drugs Ther. 27, 171-179
35. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., and Zhang, C. (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 104, 476-487
36. Fleissner, F., Jazbutyte, V., Fiedler, J., Gupta, S. K., Yin, X., Xu, Q., Galuppo, P., Kneitz, S.,Mayr,M., Ertl, G., Bauersachs, J., and Thum, T. (2010) Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ. Res. 107, 138-143
37. Kang, H., and Hata, A. (2012) MicroRNA regulation of smooth muscle gene expression and phenotype. Curr. Opin. Hematol. 19, 224-231
38. Albinsson, S., and Swärd, K. (2013) Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol. Res. 75, 28-36
39. Boettger, T., Beetz,N., Kostin, S., Schneider, J., Krüger,M., Hein, L., and Braun, T. (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634-2647
40. Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H.,Dean,D.B., and Zhang, C. (2007) MicroRNA expression signature and antisensemediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100, 1579-1588
41. Elia, L., Quintavalle, M., Zhang, J., Contu, R., Cossu, L., Latronico, M. V. G., Peterson, K. L., Indolfi, C., Catalucci, D., Chen, J., Courtneidge, S. A., and Condorelli,G. (2009) The knockout ofmiR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis inmice: correlates with human disease. Cell Death Differ. 16, 1590-1598
42. Xin, M., Small, E.M., Sutherland, L. B., Qi, X., McAnally, J., Plato, C. F., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166-2178
43. Edinger,R.S.,Coronnello,C.,Bodnar,A. J.,LaFramboise,W.A.,Benos, P.V., Ho, J., Johnson, J. P.,Butterworth,M.B., Bhalla,V., andLabarca, M. (2014) Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport. J. Am. Soc. Nephrol. 25, 2445-2457
44. Elvira-Matelot, E., Zhou, X. O., Farman, N., Beaurain, G., Henrion-Caude, A., Hadchouel, J., and Jeunemaitre, X. (2010) Regulation of WNK1 expression bymiR-192 and aldosterone. J. Am. Soc. Nephrol. 21, 1724-1731
45. Zhang, Y.,Huang,X.R.,Wei, L.H.,Chung,A.C., Yu,C.M., andLan, H. Y. (2014) miR-29b as a therapeutic agent for angiotensin IIinduced cardiac fibrosis by targeting TGF-b/Smad3 signaling. Mol. Ther. 22, 974-985
46. Liu, G. X., Li, Y. Q., Huang, X. R., Wei, L. H., Zhang, Y., Feng, M., Meng, X. M., Chen, H. Y., Shi, Y. J., and Lan, H. Y. (2014) Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension. Clin. Sci. 127, 195-208
47. Zhang, Z., Zou, J., Wang, G.-K., Zhang, J.-T., Huang, S., Qin, Y.-W., and Jing, Q. (2011) Uracils at nucleotide position 9-11 are required for the rapid turnover of miR-29 family. Nucleic Acids Res. 39, 4387-4395
48. Ramachandran, V., and Chen,X. (2008) Degradation ofmicroRNAs by a family of exoribonucleases in Arabidopsis. Science 321, 1490-1492
49. Zhang, Z., Qin, Y. W., Brewer, G., and Jing, Q. (2012) MicroRNA degradation and turnover: regulating the regulators. Wiley Interdiscip. Rev. RNA 3, 593-600
50. Diederichs, S., and Haber, D. A. (2007) Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097-1108
51. Van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., and Olson, E. N. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105, 13027-13032
52. Ott, C. E., Grünhagen, J., Jäger, M., Horbelt, D., Schwill, S., Kallenbach, K., Guo, G., Manke, T., Knaus, P., Mundlos, S., and Robinson, P. N. (2011) MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 39 UTR and coding-sequence binding sites. PLoS One 6, e16250
53. Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., Cooper, M. E., and Kantharidis, P. (2012) Suppression of microRNA-29 expression by TGF-b1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 23, 252-265
54. Liu, Y., Taylor, N. E., Lu, L., Jr., Usa, K., Cowley, A.W., Jr., Ferreri, N.R., Yeo, N. C., andLiang, M. (2010) RenalmedullarymicroRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55, 974-982
55. Lee, J., Lim, S., Song, B. W., Cha, M. J., Ham, O., Lee, S. Y., Lee, C., Park, J.H.,Bae, Y., Seo, H. H., Seung,M., Choi,E., andHwang,K.C. (2015) MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation. J. Cell. Biochem. 116, 598-608
56. Wang, C., Bian, Z., Wei, D., and Zhang, J. G. (2011)miR-29b regulates migration of human breast cancer cells.Mol. Cell. Biochem. 352, 197-207
57. Chen, K.-C., Wang, Y.-S., Hu, C.-Y., Chang, W.-C., Liao, Y.-C., Dai, C.-Y., and Juo, S.-H. H. (2011) OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 25, 1718-1728
58. Montezano, A.C., Callera,G.E., Yogi, A., He, Y., Tostes, R. C., He,G., Schiffrin, E. L., and Touyz, R. M. (2008) Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler. Thromb. Vasc. Biol. 28, 1511-1518
59. Garzon, R., Heaphy, C. E., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., Andreeff, M., and Croce, C. M. (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114, 5331-5341
60. Rossi, M., Pitari, M. R., Amodio, N., Di Martino, M. T., Conforti, F., Leone, E., Botta, C., Paolino, F. M., Del Giudice, T., Iuliano, E., Caraglia,M., Ferrarini, M.,Giordano, A.,Tagliaferri, P., andTassone, P. (2013) miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J. Cell. Physiol. 228, 1506-1515
61. Kin, K., Miyagawa, S., Fukushima, S., Shirakawa, Y., Torikai, K., Shimamura, K., Daimon, T., Kawahara, Y., Kuratani, T., and Sawa, Y. (2012) Tissue-and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 1, e000745
62. Shi, M. A., and Shi, G. P. (2010) Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases. Sci. Signal. 3, pe40
63. Li, P., Guo, W.,Du, L.,Zhao, J.,Wang, Y.,Liu,L., Hu, Y., andHou, Y. (2013) microRNA-29b contributes to pre-eclampsia through its effects on apoptosis, invasion and angiogenesis of trophoblast cells. Clin. Sci. 124, 27-40
64. Mott, J. L., Kobayashi, S., Bronk, S. F., and Gores,G. J. (2007)mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26, 6133-6140
65. Chen, D., Chen, Z., Park, C., Centrella, M., McCarthy, T., Chen, L., Al-Omari, A., and Moeckel, G. W. (2013) Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms. Gene 531, 23-30